{"id":"https://openalex.org/W1785041189","doi":null,"title":"Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers.","display_name":"Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers.","publication_year":1996,"publication_date":"1996-02-01","ids":{"openalex":"https://openalex.org/W1785041189","mag":"1785041189","pmid":"https://pubmed.ncbi.nlm.nih.gov/8564973"},"language":"en","primary_location":{"id":"pmid:8564973","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8564973","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Clinical Trial"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005621340","display_name":"Elise C. Kohn","orcid":"https://orcid.org/0000-0002-8631-9762","observed_orcids":["https://orcid.org/0000-0002-8631-9762"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E C Kohn","raw_affiliation_strings":["Clinical Pharmacology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110215274","display_name":"E Reed","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Reed","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034364793","display_name":"Gisele Sarosy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Sarosy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110104225","display_name":"Michaele Christian","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Christian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112243123","display_name":"Charles J. Link","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C J Link","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005796905","display_name":"Kristina Ann Cole","orcid":"https://orcid.org/0000-0003-0064-2882","observed_orcids":["https://orcid.org/0000-0003-0064-2882"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Cole","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079418869","display_name":"William Douglas Figg","orcid":"https://orcid.org/0000-0003-2428-5613","observed_orcids":["https://orcid.org/0000-0003-2428-5613"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W D Figg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113517313","display_name":"Patricia Anne Davis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P A Davis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109838408","display_name":"J Jacob","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Jacob","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054859712","display_name":"Barry R. Goldspiel","orcid":"https://orcid.org/0000-0003-1403-989X","observed_orcids":["https://orcid.org/0000-0003-1403-989X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B Goldspiel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5109233734","display_name":"Lance A. Liotta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L A Liotta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.0291,"has_fulltext":false,"cited_by_count":109,"citation_normalized_percentile":{"value":0.92095426,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"56","issue":"3","first_page":"569","last_page":"73"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.4957999885082245,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.4957999885082245,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.23600000143051147,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.0640999972820282,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.6129999756813049},{"id":"https://openalex.org/keywords/refractory-solid-tumors","display_name":"refractory solid tumors","score":0.796999990940094},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.7390000224113464},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.6610000133514404},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7419999837875366},{"id":"https://openalex.org/keywords/gastrointestinal-toxicity","display_name":"gastrointestinal toxicity","score":0.7329999804496765},{"id":"https://openalex.org/keywords/sensory-axonal-neuropathy","display_name":"sensory axonal neuropathy","score":0.8669999837875366},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9929999709129333},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.843999981880188},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/stable-disease","display_name":"stable disease","score":0.578000009059906}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6909840106964111},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.593736469745636},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5661900043487549},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5487901568412781},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.49015459418296814},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.4775486886501312},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4053660035133362},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38331055641174316}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:8564973","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8564973","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Clinical Trial"},{"id":"mag:1785041189","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8564973","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8399999737739563}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1561226826","https://openalex.org/W1583343397","https://openalex.org/W1592201456","https://openalex.org/W1912071596","https://openalex.org/W2025448048","https://openalex.org/W2043869143","https://openalex.org/W2059474107","https://openalex.org/W2086640970","https://openalex.org/W2091720851","https://openalex.org/W2114401576","https://openalex.org/W2122048408","https://openalex.org/W2148553679","https://openalex.org/W2170206497","https://openalex.org/W2262509684","https://openalex.org/W2463440568"],"related_works":["https://openalex.org/W1970649592","https://openalex.org/W1810873030","https://openalex.org/W1862177293","https://openalex.org/W2158301906","https://openalex.org/W6940666367","https://openalex.org/W7098937463","https://openalex.org/W2372442000","https://openalex.org/W2021713593","https://openalex.org/W1580692934","https://openalex.org/W2383850990"],"abstract_inverted_index":{"Carboxyamido-triazole":[0],"(CAI)":[1],"is":[2,27],"a":[3,28,52,82],"synthetic":[4],"inhibitor":[5],"of":[6,21,35,42,94,125,132,154,160,175,182,218,250],"non-excitable":[7],"calcium":[8,22],"channels":[9],"that":[10],"reversibly":[11],"inhibits":[12],"angiogenesis,":[13],"tumor":[14],"cell":[15,273,293],"proliferation,":[16],"and":[17,24,39,81,111,116,138,179,188,197,232,241,261,281,291,313],"metastatic":[18],"potential.":[19],"Inhibition":[20],"influx":[23],"calcium-dependent":[25],"events":[26],"potential":[29],"common":[30],"mechanism":[31],"underlying":[32],"these":[33],"effects":[34],"CAI.":[36,258],"The":[37,298],"cytostatic":[38],"antiangiogenic":[40],"properties":[41],"CAI":[43,69,79,86,95,128,141,213],"led":[44],"to":[45,58,105],"its":[46],"development":[47],"for":[48,169],"clinical":[49,55],"investigation.":[50],"In":[51],"Phase":[53,300],"I":[54],"trial":[56,305],"open":[57],"patients":[59,65,252,270],"with":[60,271],"refractory":[61],"solid":[62],"tumors,":[63],"49":[64],"received":[66],"p.o.":[67,126],"administered":[68,92,127],"daily":[70],"or":[71,100,162,223],"every":[72],"other":[73],"day.":[74],"Two":[75],"oral":[76],"formulations,":[77],"PEG-400":[78],"solution":[80],"gelatin":[83,184,318],"capsule":[84,185,319],"containing":[85],"in":[87,108,114,117,148,234,243,248,264,269,309,316],"PEG-400,":[88],"were":[89,166,203],"tested.":[90],"All":[91],"dosages":[93],"yielded":[96],"plasma":[97],"concentration":[98],"at":[99,143,172,207],"above":[101],"the":[102,167,176,183,208,310,317],"range":[103],"demonstrated":[104],"be":[106],"effective":[107],"inhibiting":[109],"signaling":[110],"cancer":[112,288,295],"progression":[113,256],"vitro":[115],"preclinical":[118],"models":[119],"(1":[120],"microgram/ml,":[121],"2.3":[122],"microM).":[123],"Toxicity":[124],"most":[129],"commonly":[130],"consisted":[131],"dose-related":[133],"grade":[134],"1-2":[135],"nausea,":[136],"vomiting,":[137],"occasional":[139],"anorexia.":[140],"administration":[142],"bedtime":[144],"ameliorated":[145],"gastrointestinal":[146],"complaints":[147,165],"many":[149],"patients;":[150],"others":[151],"required":[152],"addition":[153],"simple":[155],"antiemetic":[156],"regimens,":[157],"usually":[158],"consisting":[159],"metoclopropamide":[161],"prochlorperazine.":[163],"Gastrointestinal":[164],"cause":[168],"compliance-limiting":[170],"toxicity":[171],"175":[173],"mg/m2/day":[174,181,308,315],"liquid":[177,212,311],"formulation":[178],"125":[180],"formation.":[186,320],"Reversible":[187],"rare":[189],"sensory":[190],"axonal":[191],"neuropathy":[192],"(grade":[193,199],"3,":[194],"1":[195,201],"patient)":[196,202],"neutropenia":[198],"4,":[200],"dose-limiting":[204],"toxicities":[205],"observed":[206,247],"330":[209],"mg/m2":[210],"every-other-day":[211],"dose":[214],"level.":[215],"No":[216],"evidence":[217],"cumulative":[219],"end":[220],"organ":[221],"damage":[222],"central":[224],"nervous":[225],"system":[226],"injury":[227],"was":[228,237,246,267],"observed.":[229,238],"Disease":[230,239,259],"stabilization":[231,240,260],"improvement":[233,242,263],"performance":[235,244,265],"status":[236,245,266],"49%":[249],"evaluable":[251],"who":[253],"had":[254],"disease":[255],"before":[257],"associated":[262],"seen":[268],"renal":[272],"carcinoma":[274],"(7":[275,285,289],"months),":[276,283,286,290],"pancreaticobiliary":[277],"carcinomas":[278],"(3,":[279],"5,":[280],"5":[282],"melanoma":[284],"ovarian":[287],"non-small":[292],"lung":[294],"(3":[296],"months).":[297],"recommended":[299],"II":[301],"doses":[302],"from":[303],"this":[304],"are":[306],"150":[307],"formation":[312],"100":[314]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}